Safety and Efficacy of Camrelizumab in Combination With Nab-Paclitaxel Plus S-1 for the Treatment of Gastric Cancer With Serosal Invasion

OBJECTIVE: To investigate the safety and efficacy of camrelizumab in combination with nab-paclitaxel plus S-1 for the treatment of gastric cancer with serosal invasion. METHOD: Two hundred patients with gastric cancer with serosal invasion who received neoadjuvant therapy from January 2012 to Decemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ju-Li, Lin, Jian-Xian, Lin, Jun Peng, Zheng, Chao-Hui, Li, Ping, Xie, Jian-Wei, Wang, Jia-bin, Lu, Jun, Chen, Qi-Yue, Huang, Chang-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805791/
https://www.ncbi.nlm.nih.gov/pubmed/35116023
http://dx.doi.org/10.3389/fimmu.2021.783243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805791/
https://www.ncbi.nlm.nih.gov/pubmed/35116023
http://dx.doi.org/10.3389/fimmu.2021.783243

Ejemplares similares